Dina Manetti

12PUBLICATIONS
25CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
Targeting Protein Tyrosine Phosphatase 1B: Recent Advances in Natural, Synthetic, and Multitarget Inhibitors for Diabetes Therapy.

|May 01, 2026
Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuropathic Pain in Mice.

|Jul 27, 2024
Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold.

Laura Braconi, Chiara Riganti, Astrid Parenti

|Jan 11, 2024
Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023.

Maria Novella Romanelli, Laura Braconi, Alessio Gabellini

|Jun 30, 2023
DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole fumarate), a Novel Derivative of Ibogamine, Inhibits α7 and α9α10 Nicotinic Acetylcholine Receptors by Different Allosteric Mechanisms.

Han-Shen Tae, Marcelo O Ortells, Bassel J Tekarli

|Feb 11, 2023
Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators.

Dina Manetti, Silvia Dei, Hugo R Arias

Pageof 2

Frequent Collaborators

12 joint publications

Maria Novella Romanelli

8 joint publications

Elisabetta Teodori

7 joint publications

Laura Braconi

5 joint publications

Gianluca Bartolucci